Latest Insider Transactions at Amgen Inc (AMGN)
This section provides a real-time view of insider transactions for Amgen Inc (AMGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AMGEN INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AMGEN INC's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 07
2017
|
Cynthia M Patton SVP & CCO |
BUY
Grant, award, or other acquisition
|
Direct |
5,003
+16.44%
|
-
|
Mar 07
2017
|
David Piacquad SVP, Business Development |
BUY
Grant, award, or other acquisition
|
Direct |
5,635
+12.92%
|
-
|
Mar 07
2017
|
Esteban Santos EVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
5,003
+13.14%
|
-
|
Mar 07
2017
|
Annette Louise Such VP, Finance and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
1,408
+14.01%
|
-
|
Feb 07
2017
|
Lori A Johnston EVP, HR |
BUY
Grant, award, or other acquisition
|
Direct |
4,795
+26.47%
|
-
|
Jan 31
2017
|
Brian M Mcnamee EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
585
-0.66%
|
$90,090
$154.43 P/Share
|
Jan 31
2017
|
Cynthia M Patton SVP & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
136
-0.66%
|
$20,944
$154.43 P/Share
|
Jan 31
2017
|
Sean E Harper EVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
668
-1.47%
|
$102,872
$154.43 P/Share
|
Jan 31
2017
|
Anthony C Hooper EVP, Global Commercial Ops. |
SELL
Payment of exercise price or tax liability
|
Direct |
668
-0.36%
|
$102,872
$154.43 P/Share
|
Jan 31
2017
|
Robert A Bradway Chairman, CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,780
-0.79%
|
$428,120
$154.43 P/Share
|
Jan 31
2017
|
Esteban Santos EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
152
-0.54%
|
$23,408
$154.43 P/Share
|
Jan 30
2017
|
Esteban Santos EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
140
-0.49%
|
$21,980
$157.16 P/Share
|
Jan 30
2017
|
David W Meline EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
529
-1.03%
|
$83,053
$157.16 P/Share
|
Jan 30
2017
|
David Piacquad SVP, Business Development |
SELL
Payment of exercise price or tax liability
|
Direct |
160
-0.49%
|
$25,120
$157.16 P/Share
|
Jan 30
2017
|
Cynthia M Patton SVP & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
113
-0.55%
|
$17,741
$157.16 P/Share
|
Jan 30
2017
|
Sean E Harper EVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
513
-1.12%
|
$80,541
$157.16 P/Share
|
Jan 30
2017
|
Anthony C Hooper EVP, Global Commercial Ops. |
SELL
Payment of exercise price or tax liability
|
Direct |
598
-0.32%
|
$93,886
$157.16 P/Share
|
Jan 30
2017
|
Robert A Bradway Chairman, CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,417
-0.68%
|
$379,469
$157.16 P/Share
|
Jan 30
2017
|
Brian M Mcnamee EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
449
-0.5%
|
$70,493
$157.16 P/Share
|
Jan 28
2017
|
Cynthia M Patton SVP & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
279
-1.33%
|
$43,803
$157.16 P/Share
|
Jan 28
2017
|
Sean E Harper EVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
1,056
-2.25%
|
$165,792
$157.16 P/Share
|
Jan 28
2017
|
Anthony C Hooper EVP, Global Commercial Ops. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,053
-0.56%
|
$165,321
$157.16 P/Share
|
Jan 28
2017
|
Robert A Bradway Chairman, CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,673
-0.75%
|
$419,661
$157.16 P/Share
|
Jan 28
2017
|
Brian M Mcnamee EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
582
-0.65%
|
$91,374
$157.16 P/Share
|
Nov 01
2016
|
Ellen Jamison Kullman Director |
BUY
Grant, award, or other acquisition
|
Direct |
355
+46.41%
|
-
|
Oct 26
2016
|
Cynthia M Patton SVP & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,043
-4.75%
|
$163,751
$157.9 P/Share
|
Oct 25
2016
|
Brian M Mcnamee EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
2,109
-2.29%
|
$333,222
$158.76 P/Share
|
Sep 09
2016
|
Francois De Carbonnel Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,604
-12.3%
|
$442,680
$170.97 P/Share
|
Sep 09
2016
|
Francois De Carbonnel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+19.11%
|
$355,000
$71.64 P/Share
|
Aug 04
2016
|
Jonathan P Graham EVP & Gen. Counsel & Secy. |
SELL
Payment of exercise price or tax liability
|
Direct |
6,570
-12.32%
|
$1,136,610
$173.43 P/Share
|
Aug 02
2016
|
Annette Louise Such VP, Finance and CAO |
SELL
Open market or private sale
|
Direct |
3,000
-29.46%
|
$522,000
$174.59 P/Share
|
Aug 01
2016
|
Annette Louise Such VP, Finance and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
258
-2.47%
|
$44,376
$172.03 P/Share
|
Aug 01
2016
|
David W Meline EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,766
-11.77%
|
$1,163,752
$172.03 P/Share
|
Jun 08
2016
|
Judith C Pelham Director |
SELL
Bona fide gift
|
Direct |
3,167
-24.05%
|
-
|
May 04
2016
|
Madhavan Balachandran EVP, Operations |
SELL
Open market or private sale
|
Indirect |
30,000
-34.89%
|
$4,620,000
$154.12 P/Share
|
May 03
2016
|
David Baltimore Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,279
+3.66%
|
-
|
May 03
2016
|
Frank Biondi Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,279
+3.53%
|
-
|
May 03
2016
|
Vance D Coffman Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,279
+2.89%
|
-
|
May 03
2016
|
Francois De Carbonnel Director |
SELL
Payment of exercise price or tax liability
|
Direct |
307
-1.86%
|
$48,506
$158.99 P/Share
|
May 03
2016
|
Francois De Carbonnel Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,279
+7.21%
|
-
|
May 03
2016
|
Robert Eckert Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,279
+15.92%
|
-
|
May 03
2016
|
Greg C. Garland Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,279
+21.41%
|
-
|
May 03
2016
|
Fred Hassan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,279
+20.83%
|
-
|
May 03
2016
|
Rebecca M Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,279
+11.17%
|
-
|
May 03
2016
|
Frank C Herringer Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,279
+4.05%
|
-
|
May 03
2016
|
Tyler Jacks Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,279
+16.98%
|
-
|
May 03
2016
|
Judith C Pelham Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,279
+8.85%
|
-
|
May 03
2016
|
Ronald D Sugar Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,279
+11.54%
|
-
|
May 03
2016
|
R Sanders Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,279
+31.52%
|
-
|
May 03
2016
|
Madhavan Balachandran EVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
3,581
+13.42%
|
-
|